Literature DB >> 29168431

Nucleolin phosphorylation regulates PARN deadenylase activity during cellular stress response.

Xiaokan Zhang1, Shu Xiao2, Rachele Dolce Rameau2, Emral Devany1, Zaineb Nadeem2, Elif Caglar2, Kenneth Ng2, Frida Esther Kleiman1, Anjana Saxena2.   

Abstract

Nucleolin (NCL) is an abundant stress-responsive, RNA-binding phosphoprotein that controls gene expression by regulating either mRNA stability and/or translation. NCL binds to the AU-rich element (ARE) in the 3'UTR of target mRNAs, mediates miRNA functions in the nearby target sequences, and regulates mRNA deadenylation. However, the mechanism by which NCL phosphorylation affects these functions and the identity of the deadenylase involved, remain largely unexplored. Earlier we demonstrated that NCL phosphorylation is vital for cell cycle progression and proliferation, whereas phosphorylation-deficient NCL at six consensus CK2 sites confers dominant-negative effect on proliferation by increasing p53 expression, possibly mimicking cellular DNA damage conditions. In this study, we show that NCL phosphorylation at those CK2 consensus sites in the N-terminus is necessary to induce deadenylation upon oncogenic stimuli and UV stress. NCL-WT, but not hypophosphorylated NCL-6/S*A, activates poly (A)-specific ribonuclease (PARN) deadenylase activity. We further demonstrate that NCL interacts directly with PARN, and under non-stress conditions also forms (a) complex (es) with factors that regulate deadenylation, such as p53 and the ARE-binding protein HuR. Upon UV stress, the interaction of hypophosphorylated NCL-6/S*A with these proteins is favored. As an RNA-binding protein, NCL interacts with PARN deadenylase substrates such as TP53 and BCL2 mRNAs, playing a role in their downregulation under non-stress conditions. For the first time, we show that NCL phosphorylation offers specificity to its protein-protein, protein-RNA interactions, resulting in the PARN deadenylase regulation, and hence gene expression, during cellular stress responses.

Entities:  

Keywords:  DDR; Nucleolin; PARN; post-transcription

Mesh:

Substances:

Year:  2017        PMID: 29168431      PMCID: PMC5798948          DOI: 10.1080/15476286.2017.1408764

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  54 in total

1.  Protein phosphorylation sites regulate the function of the bipartite NLS of nucleolin.

Authors:  M S Schwab; C Dreyer
Journal:  Eur J Cell Biol       Date:  1997-08       Impact factor: 4.492

2.  Nucleolin inhibits Hdm2 by multiple pathways leading to p53 stabilization.

Authors:  A Saxena; C J Rorie; D Dimitrova; Y Daniely; J A Borowiec
Journal:  Oncogene       Date:  2006-06-05       Impact factor: 9.867

3.  High levels of nucleolar expression of nucleolin are associated with better prognosis in patients with stage II pancreatic ductal adenocarcinoma.

Authors:  Lan Peng; John Liang; Hua Wang; Xianzhou Song; Asif Rashid; Henry F Gomez; Lynda J Corley; James L Abbruzzese; Jason B Fleming; Douglas B Evans; Huamin Wang
Journal:  Clin Cancer Res       Date:  2010-07-13       Impact factor: 12.531

4.  The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

Authors:  F J Stott; S Bates; M C James; B B McConnell; M Starborg; S Brookes; I Palmero; K Ryan; E Hara; K H Vousden; G Peters
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

5.  The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells.

Authors:  Sridharan Soundararajan; Weiwei Chen; Eleanor K Spicer; Nigel Courtenay-Luck; Daniel J Fernandes
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

6.  Nucleolin stabilizes Bcl-X L messenger RNA in response to UVA irradiation.

Authors:  Jack Zhang; George Tsaprailis; G Tim Bowden
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701

7.  Nucleolin mediates microRNA-directed CSF-1 mRNA deadenylation but increases translation of CSF-1 mRNA.

Authors:  Ho-Hyung Woo; Terri Baker; Csaba Laszlo; Setsuko K Chambers
Journal:  Mol Cell Proteomics       Date:  2013-03-07       Impact factor: 5.911

Review 8.  Modulation of poly(A)-specific ribonuclease (PARN): current knowledge and perspectives.

Authors:  N A A Balatsos; P Maragozidis; D Anastasakis; C Stathopoulos
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

9.  hnRNP C increases amyloid precursor protein (APP) production by stabilizing APP mRNA.

Authors:  L E Rajagopalan; C J Westmark; J A Jarzembowski; J S Malter
Journal:  Nucleic Acids Res       Date:  1998-07-15       Impact factor: 16.971

10.  Role of HuR and p38MAPK in ultraviolet B-induced post-transcriptional regulation of COX-2 expression in the human keratinocyte cell line HaCaT.

Authors:  Niklas S Fernau; Dominik Fugmann; Martin Leyendecker; Kerstin Reimann; Susanne Grether-Beck; Stefanie Galban; Niloofar Ale-Agha; Jean Krutmann; Lars-Oliver Klotz
Journal:  J Biol Chem       Date:  2009-11-16       Impact factor: 5.157

View more
  5 in total

Review 1.  Connections between 3' end processing and DNA damage response: Ten years later.

Authors:  Michael Robert Murphy; Frida Esther Kleiman
Journal:  Wiley Interdiscip Rev RNA       Date:  2019-10-28       Impact factor: 9.957

2.  Emerging Roles for the Nucleolus 2019.

Authors:  Susan J Baserga; Patrick J DiMario; Francesca E Duncan
Journal:  J Biol Chem       Date:  2020-04-17       Impact factor: 5.157

3.  Opportunities and Challenges in Global Quantification of RNA-Protein Interaction via UV Cross-Linking.

Authors:  Carlos H Vieira-Vieira; Matthias Selbach
Journal:  Front Mol Biosci       Date:  2021-05-13

Review 4.  The Importance of Small Non-Coding RNAs in Human Reproduction: A Review Article.

Authors:  Behnam Kamalidehghan; Mohsen Habibi; Sara S Afjeh; Maryam Shoai; Saeideh Alidoost; Rouzbeh Almasi Ghale; Nahal Eshghifar; Farkhondeh Pouresmaeili
Journal:  Appl Clin Genet       Date:  2020-01-08

5.  The nucleolus is the site for inflammatory RNA decay during infection.

Authors:  Taeyun A Lee; Heonjong Han; Ahsan Polash; Seok Keun Cho; Ji Won Lee; Eun A Ra; Eunhye Lee; Areum Park; Sujin Kang; Junhee L Choi; Ji Hyun Kim; Ji Eun Lee; Kyung-Won Min; Seong Wook Yang; Markus Hafner; Insuk Lee; Je-Hyun Yoon; Sungwook Lee; Boyoun Park
Journal:  Nat Commun       Date:  2022-09-03       Impact factor: 17.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.